Enriqueta F. F.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
- Dose-Escalation Study of Zongertinib in Patients with Advanced Non-Small Cell Lung Cancer and Solid Tumors with HER2 Aberrations
- Phase 1 Study of SHP2 Inhibitor BBP-398 and KRAS-G12C Inhibitor Sotorasib in Advanced Solid Tumors with KRAS-G12C Mutation
Data & Insights
Has run more than one trial at 510 of 827 partner sites.
Specializations
Non-Small Cell Lung Cancer
The investigator specializes in conducting clinical research on advanced and metastatic non-small cell lung cancer (NSCLC), with particular emphasis on novel therapeutic approaches and treatment combinations.
- First-line treatment strategies
- Immunotherapy combinations
- Targeted therapies for specific mutations
Their work encompasses various NSCLC subtypes, including squamous and non-squamous variants, with special attention to EGFR-mutated and KRAS G12C-positive cases.
Small Cell Lung Cancer
The investigator conducts research on advanced small cell lung cancer (SCLC) and neuroendocrine carcinomas, exploring innovative treatment approaches.
- Novel therapeutic combinations
- Second-line treatment options
- Immunotherapy applications
Their work includes evaluation of treatment responses and survival outcomes in SCLC patients.
Advanced Solid Tumors
The investigator studies advanced solid tumors across multiple indications, focusing on innovative therapeutic approaches and novel drug combinations.
- First-in-human studies
- Biomarker-driven therapies
- Multi-cancer applications
Research includes evaluation of novel immunotherapy combinations and targeted therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.